Dicerna Pharmaceuticals Analysis
Dicerna Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Dicerna Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Dicerna Pharmaceuticals is worth, separate from its market price. There are two main types of Dicerna Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Dicerna Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Dicerna Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Dicerna Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Dicerna Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Dicerna Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Dicerna Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Dicerna |
Dicerna Stock Analysis Notes
About 89.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.63. Dicerna Pharmaceuticals had not issued any dividends in recent years. Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference -based pharmaceuticals. As of December 27, 2021, Dicerna Pharmaceuticals, Inc. operates as a subsidiary of Novo Nordisk AS. Dicerna Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 302 people. To learn more about Dicerna Pharmaceuticals call Douglas Fambrough at 617 621-8097 or check out www.dicerna.com.Dicerna Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Dicerna Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Dicerna Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Dicerna Pharmaceuticals is not yet fully synchronised with the market data | |
| Dicerna Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Dicerna Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 192.85 M. Net Loss for the year was (124.44 M) with loss before overhead, payroll, taxes, and interest of (41.08 M). | |
| Over 89.0% of the company shares are held by institutions such as insurance companies |
Dicerna Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dicerna Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Dicerna Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Dicerna Profitablity
Dicerna Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Dicerna Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Dicerna Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Dicerna Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Dicerna Pharmaceuticals' profitability requires more research than a typical breakdown of Dicerna Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (64.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (62.88) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $62.88.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Dicerna Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Dicerna Stock
If you are still planning to invest in Dicerna Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dicerna Pharmaceuticals' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Transaction History View history of all your transactions and understand their impact on performance |